Looks like another good result with full year EPS exceeding 6cs and dividend yield of at least 5% franked. at current price of 61.5 looks very cheap imo.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
